Espironolactona

Espironolactona may be available in the countries listed below.

Ingredient matches for Espironolactona

Spironolactone

Spironolactone is reported as an ingredient of Espironolactona in the following countries:

• Chile


• Colombia


• Ecuador


• Venezuela

International Drug Name Search

Durezol Emulsion

Pronunciation: DYE-floo-PRED-nate
Generic Name: Difluprednate
Brand Name: Durezol

Durezol Emulsion is used for:

Treating swelling, pain, redness, or irritation of the eye after eye surgery.

Durezol Emulsion is an ophthalmic corticosteroid. It decreases inflammation (eg, pain, redness, swelling, warmth) of the eye.

Do NOT use Durezol Emulsion if:

• you are allergic to any ingredient in Durezol Emulsion


• you have a bacterial, viral, mycobacterial, or fungal infection of the eye

Contact your doctor or health care provider right away if any of these apply to you.

Before using Durezol Emulsion:

Some medical conditions may interact with Durezol Emulsion. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you wear soft contact lenses


• if you have cataract surgery, diabetes, eye discharge, thinning of the cornea or sclera, glaucoma, or increased eye pressure


• if you have a history of herpes simplex of the eye

Some MEDICINES MAY INTERACT with Durezol Emulsion. However, no specific interactions with Durezol Emulsion are known at this time.

Ask your health care provider if Durezol Emulsion may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Durezol Emulsion:

Use Durezol Emulsion as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Durezol Emulsion is only for the eye. Do not get it in your nose or mouth.


• Shake well before each use.


• To use Durezol Emulsion in the eye, first, wash your hands. Tilt your head back. Using your index finger, pull the lower eyelid away from the eye to form a pouch. Drop the medicine into the pouch and gently close your eyes. Immediately use your finger to apply pressure to the inside corner of the eyelid for 1 to 2 minutes. Do not blink. Remove excess medicine around your eye with a clean, dry tissue, being careful not to touch your eye. Wash your hands to remove any medicine that may be on them.


• To prevent germs from contaminating your medicine, do not touch the applicator tip to any surface, including the eye. Keep the container tightly closed.


• If you miss a dose of Durezol Emulsion, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Durezol Emulsion.

Important safety information:

• Durezol Emulsion may cause blurred vision. Use Durezol Emulsion with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Soft contact lenses may absorb a chemical in Durezol Emulsion; do not wear soft contact lenses while you use Durezol Emulsion.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor. If you use Durezol Emulsion for longer than 10 days, your eyes will need to be rechecked by your eye care provider.


• If your symptoms do not get better within 2 days or if they get worse, check with your eye doctor.


• Lab tests, including eye exams, may be performed while you use Durezol Emulsion. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Durezol Emulsion should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Durezol Emulsion while you are pregnant. It is not known if Durezol Emulsion is found in breast milk. If you are or will be breast-feeding while you use Durezol Emulsion, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Durezol Emulsion:

All medicines may cause side effects, but many people have no, or minor, side effects. No COMMON side effects have been reported with Durezol Emulsion. Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); changes in vision (eg, blurred vision, decreased vision); continued or worsening itching, tearing, or irritation; delayed healing after surgery; discharge from the eye; eye pain; foreign body sensation; new or worsening redness or swelling of the eye or eyelid; sensitivity to light.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Durezol side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Durezol Emulsion:

Store Durezol Emulsion at room temperature, between 59 and 77 degrees F (15 and 25 degrees C). Store in an upright position. Do not freeze. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Durezol Emulsion out of the reach of children and away from pets.

General information:

• If you have any questions about Durezol Emulsion, please talk with your doctor, pharmacist, or other health care provider.


• Durezol Emulsion is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Durezol Emulsion. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Durezol resources

• Durezol Side Effects (in more detail)
• Durezol Use in Pregnancy & Breastfeeding
• Durezol Support Group
• 0 Reviews for Durezol - Add your own review/rating

Compare Durezol with other medications

• Postoperative Ocular Inflammation

Omed antacid

Omed antacid may be available in the countries listed below.

Ingredient matches for Omed antacid

Omeprazole

Omeprazole is reported as an ingredient of Omed antacid in the following countries:

• Switzerland

International Drug Name Search

Condyline

Condyline may be available in the countries listed below.

UK matches:

• Condyline (SPC)

Ingredient matches for Condyline

Podophyllotoxin

Podophyllotoxin is reported as an ingredient of Condyline in the following countries:

• Australia


• Canada


• Denmark


• Finland


• France


• Hungary


• Ireland


• Italy


• Netherlands


• New Zealand


• Norway


• Oman


• Poland


• Romania


• Russian Federation


• Sweden


• Switzerland


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Xycam

Xycam may be available in the countries listed below.

Ingredient matches for Xycam

Piroxicam

Piroxicam is reported as an ingredient of Xycam in the following countries:

• South Africa

International Drug Name Search

Dytan-CS

Pronunciation: car-beta-PEN-tane/dye-fen-HYE-dra-meen/fen-ill-EF-rin
Generic Name: Carbetapentane/Diphenhydramine/Phenylephrine
Brand Name: Dytan-CS

Dytan-CS is used for:

Relieving symptoms of sinus congestion, runny nose, sneezing, and cough due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.

Dytan-CS is a decongestant, antihistamine, and cough suppressant combination. The decongestant works by constricting blood vessels and reducing swelling in the nasal passages. The antihistamine works by blocking the action of histamine, which helps reduce symptoms, such as watery eyes and sneezing. The cough suppressant works in the brain to help decrease the cough reflex to reduce a dry cough.

Do NOT use Dytan-CS if:

• you are allergic to any ingredient in Dytan-CS


• you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, or severe heart problems


• you take sodium oxybate (GHB) or you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dytan-CS:

Some medical conditions may interact with Dytan-CS. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a fast, slow, or irregular heartbeat


• if you have a history of adrenal gland problems (eg, adrenal gland tumor); heart problems; high blood pressure; diabetes; heart blood vessel problems; stroke; glaucoma; a blockage of your bladder, stomach, or intestines; ulcers; trouble urinating; an enlarged prostate or other prostate problems; seizures; or an overactive thyroid


• if you have a history of asthma, chronic cough, lung problems (eg, chronic bronchitis, emphysema), or chronic obstructive pulmonary disease (COPD), or if your cough occurs with large amounts of mucus

Some MEDICINES MAY INTERACT with Dytan-CS. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Beta-blockers (eg, propranolol), cathechol-O-methyltransferase (COMT) inhibitors (eg, tolcapone), furazolidone, indomethacin, MAO inhibitors (eg, phenelzine), sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because side effects of Dytan-CS may be increased


• Digoxin or droxidopa because risk of irregular heartbeat or heart attack may be increased


• Bromocriptine because side effects ma y be increased by Dytan-CS


• Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because effectiveness may be decreased by Dytan-CS

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dytan-CS may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dytan-CS:

Use Dytan-CS as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Dytan-CS may be taken with or without food.


• If you miss a dose of Dytan-CS, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dytan-CS.

Important safety information:

• Dytan-CS may cause dizziness, drowsiness, or blurred vision. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Dytan-CS. Using Dytan-CS alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.


• Do not take diet or appetite control medicines while you are taking Dytan-CS without checking with your doctor.


• Dytan-CS contains diphenhydramine and phenylephrine. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains diphenhydramine or phenylephrine. If it does or if you are uncertain, contact your doctor or pharmacist.


• Do NOT exceed the recommended dose or take Dytan-CS for longer than prescribed without checking with your doctor.


• If your symptoms do not improve within 5 to 7 days or if they become worse, check with your doctor.


• Dytan-CS may cause increased sensitivity to the sun. Avoid exposure to the sun, sunlamps, or tanning booths until you know how you react to Dytan-CS. Use a sunscreen or protective clothing if you must be outside for a prolonged period.


• If you are scheduled for allergy skin testing, do not take Dytan-CS for several days before the test because it may decrease your response to the skin tests.


• Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Dytan-CS.


• Use Dytan-CS with caution in the ELDERLY because they may be more sensitive to its effects.


• Caution is advised when using Dytan-CS in CHILDREN because they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Dytan-CS, discuss with your doctor the benefits and risks of using Dytan-CS during pregnancy. It is unknown if Dytan-CS is excreted in breast milk. Do not breast-feed while taking Dytan-CS.

Possible side effects of Dytan-CS:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; trouble sleeping; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dytan-CS side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.

Proper storage of Dytan-CS:

Store Dytan-CS at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dytan-CS out of the reach of children and away from pets.

General information:

• If you have any questions about Dytan-CS, please talk with your doctor, pharmacist, or other health care provider.


• Dytan-CS is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dytan-CS. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dytan-CS resources

• Dytan-CS Side Effects (in more detail)
• Dytan-CS Use in Pregnancy & Breastfeeding
• Dytan-CS Drug Interactions
• Dytan-CS Support Group
• 1 Review for Dytan-CS - Add your own review/rating

• Dytan-CS Concise Consumer Information (Cerner Multum)

Compare Dytan-CS with other medications

• Cold Symptoms
• Cough and Nasal Congestion
• Hay Fever

Ritalin SR

Ritalin SR may be available in the countries listed below.

Ingredient matches for Ritalin SR

Methylphenidate

Methylphenidate hydrochloride (a derivative of Methylphenidate) is reported as an ingredient of Ritalin SR in the following countries:

• Israel


• New Zealand

International Drug Name Search

Captopril-HCT Stada

Captopril-HCT Stada may be available in the countries listed below.

Ingredient matches for Captopril-HCT Stada

Captopril

Captopril is reported as an ingredient of Captopril-HCT Stada in the following countries:

• Germany

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Captopril-HCT Stada in the following countries:

• Germany

International Drug Name Search

Bacitracin Polymyxin B

Dosage Form: ophthalmic ointment
Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP (Sterile)

Rx only

DESCRIPTION:

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP is a sterile antimicrobial ointment formulated for ophthalmic use.

Bacitracin zinc is the zinc salt of bacitracin, a mixture of related cyclic polypeptides (mainly bacitracin A) produced by the growth of an organism of the licheniformis group of Bacillus subtilis var Tracy. It has a potency of not less than 40 bacitracin units per mg. The structural formula for bacitracin A is:

Polymyxin B sulfate is the sulfate salt of polymyxin B1 and B2 which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae). It has a potency of not less than 6,000 polymyxin B units per mg, calculated on an anhydrous basis. The structural formulae are:

Each Gram Contains: ACTIVES: Bacitracin Zinc equal to 500 bacitracin units and Polymyxin B Sulfate equal to 10,000 polymyxin B units; INACTIVES: White Petrolatum and Mineral Oil.

CLINICAL PHARMACOLOGY:

Polymyxin B sulfate attacks gram-negative bacilli, including virtually all strains of Pseudomonas aeruginosa and Haemophilus influenzae species.

Bacitracin is active against most gram-positive bacilli and cocci including hemolytic streptococci.

INDlCATlONS AND USAGE:

For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate.

CONTRAINDICATIONS:

This product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

WARNINGS:

Ophthalmic ointments may retard corneal healing.

PRECAUTIONS:

As with other antibiotic preparations, prolonged use may result in overgrowth of nonsusceptible organisms, including fungi. Appropriate measures should be taken if this occurs.

DOSAGE AND ADMINISTRATION:

Apply the ointment every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection.

FOR OPHTHALMIC USE ONLY.

HOW SUPPLIED:

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP is available in tubes with an ophthalmic tip applicator in the following size:

3.5 gram tube - Prod. No. 07534

DO NOT USE IF CAP AND NECKRING ARE NOT INTACT.

Storage:

Store between 15°-25°C (59°-77°F). KEEP TIGHTLY CLOSED.

KEEP OUT OF REACH OF CHILDREN.

Revised November 2007

Bausch & Lomb Incorporated

Tampa, FL 33637

©Bausch & Lomb Incorporated

9130700 (Folded)

9130600 (Flat)

PRINCIPAL DISPLAY PANEL

NDC 24208-555-55

Bausch & Lomb

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP

(Sterile)

Rx only

[icon- eye] [icon- ointment] [icon- 3.5 gm]

Net wt. 1/8 oz (3.5g)

BACITRACIN ZINC AND POLYMYXIN B SULFATE  bacitracin zinc and polymyxin b sulfate  ointment

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 24208-555 Route of Administration OPHTHALMIC DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BACITRACIN ZINC (BACITRACIN) BACITRACIN ZINC 500   in 1 g POLYMYXIN B SULFATE (POLYMYXIN B) POLYMYXIN B SULFATE 10000   in 1 g

Inactive Ingredients Ingredient Name Strength PETROLATUM   MINERAL OIL

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 24208-555-55 1 TUBE In 1 CARTON contains a TUBE 1 3.5 g In 1 TUBE This package is contained within the CARTON (24208-555-55)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
ANDA	ANDA064046	04/25/2008

Labeler - Bausch & Lomb Incorporated (196603781)

Establishment
Name	Address	ID/FEI	Operations
Bausch & Lomb Incorporated		807927397	MANUFACTURE

Revised: 02/2011Bausch & Lomb Incorporated

More Bacitracin Polymyxin B resources

• Bacitracin Polymyxin B Dosage
• Bacitracin Polymyxin B Use in Pregnancy & Breastfeeding
• Bacitracin Polymyxin B Support Group
• 1 Review for Bacitracin Polymyxin B - Add your own review/rating

Compare Bacitracin Polymyxin B with other medications

• Blepharitis
• Blepharoconjunctivitis
• Conjunctivitis, Bacterial
• Keratitis
• Keratoconjunctivitis